← Eichor
Study identifier: NCT04613089 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database

Condition: Neuronal Ceroid Lipofuscinosis · Batten Disease · CLN1 Disease  ·  Sponsor: Universitätsklinikum Hamburg-Eppendorf

PhaseN/A
Planned participants500
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This is an observational study that aims at assessing the natural history of NCL diseases as part of the international DEM-CHILD Database. 1. Patient data are collected from medical records, patient questionnaires and routine follow up clinical examinations with focus on assessing progression in key areas of disease such as motor, language, cognition, seizures, vision, and behavior. 2. A local biorepository of samples from genetically defined NCL patients will be established as well as a virtual biorepository within the DEM-CHILD DB to be able to easily localize international availability of patient samples.

This description comes directly from the study's public registry record.

Talk to the study team

Miriam Nickel, MD  ·  +4940741020440  ·  m.nickel@uke.de

Angela Schulz, MD, PhD  ·  +4940741020440  ·  anschulz@uke.de

Always discuss trial participation with your own doctor first.

Locations (1)

University Medical Center Hamburg-EppendorfHamburg, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04613089